Diabetes, Obesity and Metabolism
Diabetes, Obesity and Metabolism is a journal indexed in SJR in Endocrinology and Endocrinology, Diabetes and Metabolism with an H index of 162. It has a price of 3857 €. It has an SJR impact factor of 2,251 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 2,251.
Diabetes, Obesity and Metabolism focuses its scope in these topics and keywords: diabetes, type, insulin, review, management, levels, people, programme, patients, adjustment, ...
Metrics
Scimago and CountryOfPapers database fields
SJR Impact
2,251
H-index
162
Docs (year)
671
Docs 3y
1029
Total refs
28570
Cites 3y
5731
Citable 3y
881
Cites/Doc 2y
5.43
Ref/Doc
42.58
Immediate OA
3857 €
Embargoed OA
NPD
Non OA / Submission
0 €
Name good journals. Call out predatory ones.
Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.
Researcher reviews
Best articles by citations
Cardiovascular risk in type 2 diabetes
View moreWhat should the role of ACE inhibitors be in the treatment of diabetes? Lessons from HOPE and MICRO-HOPE
View moreDysglycaemia in the critically ill - significance and management
View moreDo baseline serum leptin levels predict weight regain after dieting in obese women?
View moreDissociation between Fas expression and induction of apoptosis in human islets of Langerhans
View moreDifferences in treatment and metabolic abnormalities between normo- and hypertensive patients with type 2 diabetes: the Skaraborg Hypertension and Diabetes Project
View moreDifferences in pharmacotherapy and in glucose control of type 2 diabetes patients in two neighbouring towns: a longitudinal population-based study
View moreComparison of the effects of glimepiride and glibenclamide on adipose tissue tumour necrosis factor-alpha mRNA expression and cellularity
View moreComparative accuracy of cardiovascular risk prediction methods in patients with diabetes mellitus
View moreClustering of cardiovascular risk factors with diabetes in Chinese patients: the effects of sex and hyperinsulinaemia
View moreClustering of cardiovascular risk factors in type 2 diabetes mellitus: prognostic significance and tracking
View moreClinical management of diabetic nephropathy
View moreClenbuterol stimulates neurotrophic support in streptozotocin-diabetic rats
View more5-HT2C receptor modulation and the treatment of obesity
View moreCardiovascular effects of sulphonylureas: role of KATP channels
View morebeta3-Adrenergic receptor gene polymorphism and type 2 diabetes in a Caucasian population
View moreAntilipolytic drugs for the prevention of primary ventricular fibrillation
View moreAntidiabetic and toxicological evaluations of naringenin in normoglycaemic and NIDDM rat models and its implications on extra-pancreatic glucose regulation
View moreAleglitazar, a dual peroxisome proliferator-activated receptor-a/ gamma agonist, improves insulin sensitivity, glucose control and lipid levels in people with type 2 diabetes: findings from a randomized, double-blind trial
View moreAdipocyte metabolism and the metabolic syndrome
View moreAcute physiological effects of glucocorticoids on fuel metabolism in humans are permissive but not direct
View moreAcarbose vs. bedtime NPH insulin in the treatment of secondary failures to sulphonylurea-metformin therapy in type 2 diabetes mellitus
View moreA new hope in the nightmare of diabetic orthostatic hypotension: the midodrine-fludrocortisone association
View moreA new air displacement plethysmograph for the determination of Japanese body composition
View more